M. Kuş, Perihan Öztürk, H. Nazik, M. Mülayim, Tutku Bulut, Esra Rabia Akgüç, S. Koçarslan
{"title":"COVID-19后发生的毛状红斑糠疹","authors":"M. Kuş, Perihan Öztürk, H. Nazik, M. Mülayim, Tutku Bulut, Esra Rabia Akgüç, S. Koçarslan","doi":"10.4274/turkderm.galenos.2021.26235","DOIUrl":null,"url":null,"abstract":"Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor necrosis factor (adalimumab), which was not previously reported in an adult.","PeriodicalId":49412,"journal":{"name":"Turkderm-Archives of the Turkish Dermatology and Venerology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pityriasis rubra pilaris developing after COVID-19\",\"authors\":\"M. Kuş, Perihan Öztürk, H. Nazik, M. Mülayim, Tutku Bulut, Esra Rabia Akgüç, S. Koçarslan\",\"doi\":\"10.4274/turkderm.galenos.2021.26235\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor necrosis factor (adalimumab), which was not previously reported in an adult.\",\"PeriodicalId\":49412,\"journal\":{\"name\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/turkderm.galenos.2021.26235\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkderm-Archives of the Turkish Dermatology and Venerology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/turkderm.galenos.2021.26235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Pityriasis rubra pilaris developing after COVID-19
Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor necrosis factor (adalimumab), which was not previously reported in an adult.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
